A device called the Watchman— a left atrial appendage closure — gives people with atrial fibrillation an option other than taking blood-thinning drugs.
Legacy Health's Structural Heart Program was the first health care system in Oregon to offer the Watchman implant for patients with atrial fibrillation and those who want an alternative to blood-thinning drugs.
Amish J. Desai, MD, FACC, medical director of the Legacy Structural Heart Program, has participated in the clinical trials for the Watchman and has more than 10 years of experience using and implanting the device. Dr. Desai has performed more Watchman implant procedures than any doctor in the Pacific Northwest and is among the top 10 nationwide in the procedure.
Patients who may benefit from the Watchman:
- Have atrial fibrillation not caused by heart valve disease
- Have an increased risk of stroke due to atrial fibrillation
- Are taking blood-thinning medications
- Are at risk for or have had bleeding complications while taking
blood-thinning medications
- Want to consider alternatives to blood-thinning medications